MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.biomaterials.2022.121783

Медицинская библиотека · Biomaterials · 2022

Sustained potentiation of bystander killing via PTEN-loss driven macropinocytosis targeted peptide-drug conjugate therapy in metastatic triple-negative breast cancer.

Cho Young Seok, Kim Ha Rin, Park Seong Jin, Chung Seung Woo, Ko Yoon Gun, Yeo Joo Hye, Lee Jinu, Kim Sang Kyoon, Choi Jeong Uk, Kim Sang Yoon, Byun Youngro

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

While conventional approaches for PTEN-loss cancers mainly focus on turning off growth promoting process through modulation of PI3K/AKT pathways, no effective therapeutic treatments that target PTEN-loss cancer cells have yielded results. Moreover, conventional targeted therapies, which are potent against only a subset of cancer cells with limited specificity, bring on temporary response. Here, we report the development of albumin-binding caspase-3 cleavable peptide-drug conjugate (PDC), which utilizes the enhanced albumin metabolism pathway in PTEN-loss cancer cells to enhance the intracellular delivery of chemotherapeutic payload that could exert a bystander killing effect. Albumin metabolism-mediated apoptosis triggered expression of caspase-3 allows the continuous activation of the PDC, accumulation of payloads, sustained upregulation of tumoral caspase-3, and intensified in-situ apoptosis. Importantly, PDC strategy exerts potent therapeutic efficacy against PTEN-loss metastatic triple-negative breast cancer, the highly aggressive and heterogenous nature of which remains a challenge conventional targeted therapies need to overcome. This study thus presents a conceptually novel approach to treat PTEN-loss cancer and creates new translational perspectives of exploiting PTEN-loss for providing an avenue to advance current targeted therapy.

Для цитирования: Cho Young Seok, Kim Ha Rin, Park Seong Jin, Chung Seung Woo, Ko Yoon Gun, Yeo Joo Hye, Lee Jinu, Kim Sang Kyoon, Choi Jeong Uk, Kim Sang Yoon, Byun Youngro. Sustained potentiation of bystander killing via PTEN-loss driven macropinocytosis targeted peptide-drug conjugate therapy in metastatic triple-negative breast cancer.. Biomaterials. 2022. DOI: 10.1016/j.biomaterials.2022.121783.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.